![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Count data and recurrent events in clinical trials, such as the number of lesions in magnetic resonance imaging in multiple sclerosis, the number of relapses in multiple sclerosis, the number of hospitalizations in heart failure, and the number of exacerbations in asthma or in chronic obstructive pulmonary disease (COPD) are often modeled by negative binomial distributions. In this manuscript, we study planning and analyzing clinical trials with group sequential designs for negative binomial outcomes. We propose a group sequential testing procedure for negative binomial outcomes based on Wald statistics using maximum likelihood estimators. The asymptotic distribution of the proposed group sequential test statistics is derived. The finite sample size properties of the proposed group sequential test for negative binomial outcomes and the methods for planning the respective clinical trials are assessed in a simulation study. The simulation scenarios are motivated by clinical trials in chronic heart failure and relapsing multiple sclerosis, which cover a wide range of practically relevant settings. Our research assures that the asymptotic normal theory of group sequential designs can be applied to negative binomial outcomes when the hypotheses are tested using Wald statistics and maximum likelihood estimators. We also propose two methods, one based on Student’s t-distribution and one based on resampling, to improve type I error rate control in small samples. The statistical methods studied in this manuscript are implemented in the R package gscounts, which is available for download on the Comprehensive R Archive Network (CRAN).
References
| 1. | Jennison C and Turnbull BW. Group sequential designs with applications to clinical trials. Boca Raton, Florida, USA: Chapman & Hall/CRC, 2000. Google Scholar |
| 2. | Shoben, AB, Emerson, SS. Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials. Stat Med 2014; 33: 5041–5056. Google Scholar | Crossref | Medline |
| 3. | Whitehead, J . The design and analysis of sequential clinical trials, West Sussex, England: John Wiley & Sons, 1997. Google Scholar | Crossref |
| 4. | Wassmer G and Brannath W. Group sequential and confirmatory adaptive designs in clinical trials. Heidelberg, Germany: Springer, 2016. Google Scholar |
| 5. | Sormani, MP, Bruzzi, P, Miller, DH, et al. Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci 1999; 163: 74–80. Google Scholar | Crossref | Medline | ISI |
| 6. | Keene, ON, Jones, MRK, Lane, PW, et al. Analysis of exacerbation rates in asthma and chronic obstructive pulmonary disease: example from the TRISTAN study. Pharmaceut Stat 2007; 6: 89–97. Google Scholar | Crossref | Medline |
| 7. | Keene, ON, Calverley, PMA, Jones, PW, et al. Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J 2008; 32: 17–24. Google Scholar | Crossref | Medline |
| 8. | Keene, ON, Vestbo, J, Anderson, J, et al. Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J 2009; 34: 1018–1023. Google Scholar | Crossref | Medline |
| 9. | Rodés-Cabau, J, Horlick, E, Ibrahim, R, et al. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: the CANOA randomized clinical trial. J Am Med Assoc 2015; 314: 2147–2154. Google Scholar | Crossref |
| 10. | Schlesinger, N, Mysler, E, Lin, HY, et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheumat Dis 2011; 70: 1264–1271. Google Scholar | Crossref | Medline | ISI |
| 11. | Rogers, JK, Pocock, SJ, McMurray, JJV, et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Failure 2014; 16: 33–40. Google Scholar | Crossref | Medline |
| 12. | Cook, RJ, Lawless, JF. Interim monitoring of longitudinal comparative studies with recurrent event responses. Biometrics 1996; 52: 1311–1323. Google Scholar | Crossref | Medline |
| 13. | Cook, RJ, Farewell, VT. Incorporating surrogate endpoints into group sequential trials. Biometric J 1996; 38: 119–130. Google Scholar | Crossref |
| 14. | Jiang, W . Group sequential procedures for repeated events data with frailty. J Biopharmaceut Stat 1999; 9: 379–399. Google Scholar | Crossref | Medline |
| 15. | Xia, Q, Hoover, DR. A procedure for group sequential comparative Poisson trials. J Biopharmaceut Stat 2007; 16: 869–881. Google Scholar | Crossref |
| 16. | Cook, RJ, Grace, YY, Lee, KA. Sequential testing with recurrent events over multiple treatment periods. Stat Biosci 2010; 2: 137–153. Google Scholar | Crossref |
| 17. | Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Failure 2016; 18: 891–975. Google Scholar | Crossref | Medline | ISI |
| 18. | Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for the treatment of chronic heart failure, https://goo.gl/HHgONb (accessed 20 October 2016). Google Scholar |
| 19. | Rogers, JK, McMurray, JJV, Pocock, SJ, et al. Eplerenone in patients with systolic heart failure and mild symptoms analysis of repeat hospitalizations. Circulation 2012; 126: 2317–2323. Google Scholar | Crossref | Medline |
| 20. | Rogers, JK, Jhund, PS, Perez, AC, et al. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure 2014; 2: 289–297. Google Scholar | Crossref | Medline |
| 21. | Udelson, JE . Heart failure with preserved ejection fraction. Circulation 2011; 124: 540–543. Google Scholar | Crossref | Medline | ISI |
| 22. | Redfield, MM . Heart failure with preserved ejection fraction. New Engl J Med 2016; 375: 1868–1877. Google Scholar | Crossref | Medline |
| 23. | Yusuf, S, Pfeffer, MA, Swedberg, K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777–781. Google Scholar | Crossref | Medline | ISI |
| 24. | Mehta, C, Gao, P, Bhatt, DL, et al. Optimizing trial design: sequential, adaptive, and enrichment strategies. Circulation 2009; 119: 597–605. Google Scholar | Crossref | Medline | ISI |
| 25. | Jackson, N, Atar, D, Borentain, M, et al. Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. Eur Heart J 2016; 37: 747–754. Google Scholar | Crossref | Medline |
| 26. | Cohen, JA, Rudick, RA. Multiple sclerosis therapeutics, Cambridge, England: Cambridge University Press, 2011. Google Scholar | Crossref |
| 27. | Selmaj, K, Li, SKB, Hartung, HP, et al. Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study. Lancet Neurol 2013; 12: 756–767. Google Scholar | Crossref | Medline | ISI |
| 28. | Cook, RJ, Lawless, J. The statistical analysis of recurrent events, New York, NY, USA: Springer Science & Business Media, 2007. Google Scholar |
| 29. | Lawless, JF . Negative binomial and mixed Poisson regression. Can J Stat 1987; 15: 209–225. Google Scholar | Crossref | ISI |
| 30. | Gallo, P, Mao, L, Shih, VH. Alternative views on setting clinical trial futility criteria. J Biopharmaceut Stat 2014; 24: 976–993. Google Scholar | Crossref | Medline |
| 31. | Scharfstein, DO, Tsiatis, AA, Robins, JM. Semiparametric efficiency and its implication on the design and analysis of group-sequential studies. J Am Stat Assoc 1997; 92: 1342–1350. Google Scholar | Crossref |
| 32. | Jennison, C, Turnbull, BW. Group-sequential analysis incorporating covariate information. J Am Stat Assoc 1997; 92: 1330–1341. Google Scholar | Crossref | ISI |
| 33. | Lan, KKG, DeMets, DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659–663. Google Scholar | Crossref | ISI |
| 34. | Proschan, MA, Follmann, DA, Waclawiw, MA. Effects of assumption violations on type I error rate in group sequential monitoring. Biometrics 1992; 48: 1131–1143. Google Scholar | Crossref | ISI |
| 35. | Aban, IB, Cutter, GR, Mavinga, N. Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data. Computat Stat Data Analys 2009; 53: 820–833. Google Scholar | Crossref | ISI |
| 36. | Farrington, CP, Manning, G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990; 9: 1447–1454. Google Scholar | Crossref | Medline | ISI |
| 37. | Tang, NS, Tang, ML, Wang, SF. Sample size determination for matched-pair equivalence trials using rate ratio. Biostatistics 2006; 8: 625–631. Google Scholar | Crossref | Medline |
| 38. | Mütze, T, Munk, A, Friede, T. Design and analysis of three-arm trials with negative binomially distributed endpoints. Stat Med 2016; 35: 505–521. Google Scholar | Crossref | Medline |
| 39. | Pocock, SJ . Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191–199. Google Scholar | Crossref | ISI |
| 40. | Mütze, T, Konietschke, F, Munk, A, et al. A studentized permutation test for three-arm trials in the ‘gold standard’ design. Stat Med 2017; 36: 883–898. Google Scholar | Crossref | Medline |
| 41. | Spiessens, B, Debois, M. Adjusted significance levels for subgroup analyses in clinical trials. Contemporary Clin Trials 2010; 31: 647–656. Google Scholar | Crossref | Medline |
| 42. | Placzek M and Friede T. Clinical trials with nested subgroups: analysis, sample size determination and internal pilot. Stat Meth Med Res 2017; 27: 3286–3303. Google Scholar |
| 43. | Graf AC, Wassmer G, Friede T, et al. Robustness of testing procedures for confirmatory subpopulation analyses based on a continuous biomarker. Stat Meth Med Res 2017 (submitted). Google Scholar |
| 44. | Jennison C. Bootstrap tests and confidence intervals for a hazard ration when the number of observed failures is small, with applications to group sequential survival studies. In: Proceedings of the 22nd interface conference on computing science and statistics, Michigan, USA, May 1990, pp.89–97. Google Scholar |
| 45. | Mütze T. R package gscounts, https://cran.r-project.org/web/packages/gscounts/index.html (2017). Google Scholar |
| 46. | Kieser, M, Hauschke, D. Assessment of clinical relevance by considering point estimates and associated confidence intervals. Pharmaceut Stat 2005; 4: 101–107. Google Scholar | Crossref |
| 47. | Fisch, R, Jones, I, Jones, J, et al. Bayesian design of proof-of-concept trials. Therapeut Innovat Regulat Sci 2015; 49: 155–162. Google Scholar | SAGE Journals | ISI |
| 48. | Gsponer, T, Gerber, F, Bornkamp, B, et al. A practical guide to Bayesian group sequential designs. Pharmaceut Stat 2014; 13: 71–80. Google Scholar | Crossref | Medline | ISI |
| 49. | Asendorf T, Henderson R, Schmidli H, et al. Modelling and sample size reestimation for longitudinal count data with incomplete follow up. (Submitted for publication). Google Scholar |
| 50. | Committee for Medicinal Products for Human Use (CHMP). Guideline on adjustment for baseline covariates in clinical trials, https://goo.gl/YIJHEh (accessed 20 November 2016). Google Scholar |
| 51. | McCullagh, P, Nelder, JA. Generalized linear models, Boca Raton, Florida, USA: Chapman & Hall, 1989. Google Scholar | Crossref |
| 52. | Scharfstein, DO, Tsiatis, AA. The use of simulation and bootstrap in information-based group sequential studies. Stat Med 1998; 17: 75–87. Google Scholar | Crossref | Medline |
| 53. | Mehta CR and Tsiatis AA. Flexible sample size considerations using information-based interim monitoring. Drug Inform J 2001; 35: 1095–1112. Google Scholar |
| 54. | Parmar, MKB, Griffiths, GO, Spiegelhalter, DJ, et al. Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet 2001; 358: 375–381. Google Scholar | Crossref | Medline | ISI |
| 55. | Friede, T, Schmidli, H. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis. Stat Med 2010; 29: 1145–1156. Google Scholar | Medline | ISI |
| 56. | Friede, T, Schmidli, H. Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials. Meth Inform Med 2010; 49: 618–624. Google Scholar | Crossref | Medline | ISI |
